155 Induction of NSCs Quiescence and Neurogenesis Preservation in Mouse Adult Brain after FLASH Whole Brain Irradiation  by Montay-Gruel, P-G. et al.
ICTR-PHE 2016  S75 
 
The response of human peripheral blood lymphocytes (HPBL) 
was characterized using: the cytokinesis-blocked 
micronucleus (CBMN) assay, premature chromosome 
condensation (PCC) assay, FITC-Annexin V labeling 
procedure, chip-based DNA ladder assay, and the comet 
assay. The samples of whole blood or isolated lymphocytes 
collected from 10 different healthy donors were irradiated in 
vitro with 60 MeV protons or 250 kV X-rays, in the dose range 
of 0.3 Gy – 4.0 Gy. The HPBL were located in Eppendorf 
vessels located in especially prepared PMMA (Poly(methyl 
methacrylate)) phantom and irradiated with protons in the 
fully modulated Spread Out Bragg Peak (SOBP) mode. 
Dosimetry was performed in accordance to the 
recommendations of the IAEA TRS-398 protocol. 
Peripheral blood lymphocytes showed decreased ability to 
proliferate after irradiation that reduced with increasing 
radiation doses of either radiation types as evident by the 
reduced nuclear division index seen in the cytokinesis-block 
micronucleus (CBMN) assay. Proton irradiation resulted in a 
relatively higher incidence of cell death compared to those 
irradiated with X-rays. Cell death was due to both apoptosis 
and necrosis. Chip-based DNA ladder assay showed different 
degrees of fragmentation of the genomic DNA after proton 
irradiation indicating peripheral blood lymphocytes, which 
are prone to undergo an apoptotic mode of cell death, 
predominantly undergo a necrotic mode of cell death after 
proton irradiation. Differences in DNA damages following 
irradiation with protons and X-rays were apparent also at the 
intracellular distribution of cytogenetic damages as 
visualized by the PCC and CBMN assays. Alkaline comet assay 
showed a linear dose-response relationship for the DNA 
damage immediately after irradiation. Dose response 
relationship for the DNA damage indicated higher efficiency 
of protons in inducing DNA strand breaks presented as the 
ratio of the two α coefficients (1.37).   
Our results, contribute to a better understanding of the 
differences in the response of human peripheral blood 
lymphocytes to proton and X-ray irradiation. These studies 
may eventually help determine the suitability of patients 
with cancer for treatment with a given radiation type based 
on their normal tissue response and ability to predict 
treatment related adverse effects.    
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In the clinical practice of proton therapy, the biologic 
effectiveness of protons relative to photons (i.e., the 
"relative biologic effectiveness" or RBE) has simplistically 
been assumed to have a generic fixed value of 1.1.  This 
value is based on an average of results of numerous in-vitro 
and in-vivo experiments conducted under limited conditions – 
most commonly, at high doses per fraction (e.g., 6–8 Gy) and 
in the middle of the spread-out Bragg peak where the RBE is 
relatively constant and close to the average value of 1.1.  
Furthermore, the RBE data have been acquired for only a 
limited number of cell lines, tissues, and endpoints.  To 
justify the assumption of RBE of 1.1, it is argued that, 
clinically, no adverse responses have been reported with its 
use.  However, large uncertainties in the treatment 
processes may have obscured the variability of the RBE. 
In reality, the RBE is a function of multiple variables 
including dose per fraction, linear energy transfer (LET), cell 
and tissue type, endpoint, etc. It has been shown to vary 
from values lower than 1.1, perhaps lower than even 1, to as 
much as 4.  Emerging clinical evidence, still somewhat 
anecdotal, is showing that neglecting RBE variability may 
lead to unforeseen toxicities and recurrences.  However, 
establishing an unequivocal connection between unforeseen 
events and the use of RBE of 1.1 is challenging since there 
are numerous confounding factors.   These include 
uncertainty in the particle therapy dose actually delivered 
and patient-specific factors. 
As a consequence, there is a continuing debate about the 
validity of the assumption of RBE=1.1.  At the same time, 
efforts to obtain more precise and accurate RBE information 
are accelerating.  High-precision in-vitro and in-vivo 
experiments are being designed and conducted to obtain the 
large amounts of data required.  Attempts are also being 
made to extract clinically-relevant RBE from treatment 
response data, particularly from PET and MR image 
biomarkers.  Such RBE data need to be incorporated into 
predictive models of RBE, which can be used to explain 
treatment response more reliably and to design treatment 
plans.  The improved knowledge of variable RBE is expected 
to not only help explain unforeseen events but, more 
importantly, to lead to improvements in treatment planning, 
which in turn may enhance the effectiveness of proton 
therapy.  This could, for instance, be achieved by 
incorporating variable RBE in the optimization of IMPT in such 
a way as to confine high RBE protons to within the target 
volume and away from critical normal tissues. 
This presentation will focus on proton therapy.  For particles 
heavier than protons, the RBE is generally not assumed to 
have a fixed generic value.  Nevertheless, considerable 
uncertainties exist in RBE for all particles, which can have a 
significant impact on outcomes.  
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Most of adult stem cells are maintained in a quiescent state 
considered as a survival mechanism responding to DNA 
damages induced by ionizing radiation. Stem cells then are 
able to rapidly proliferate and are essential for restoration of 
tissue function. In the brain, Neural Stem Cells (NSCs) are 
known to be responsible for adult neurogenesis participating 
to cognition and Whole Brain Radiotherapy (WBRT) induces 
memory loss due to impaired neurogenesis. Here we 
compared the effect of FLASH versus conventional-RT on 
NSCs after WBRT and especially investigated quiescence and 
neurogenesis potential.  
WBRT at FLASH and conventional dose rate was performed 
using LINAC prototypes. Mice received single doses RT at 
50GyFLASH (>50Gy/s), 10GyCONV (0.04Gy/s) and sham-RT. 
Two months post-IR, before the sacrifice, cognitive tests 
were performed to evaluate memorization impairments. Two 
hours before the sacrifice animals received BrdU injection. 
Brains were collected for immunohistochemical analysis of 
NSCs quiescence using FoxO3-Sox2 (Renault et al. 2009). 
We showed that 50GyFLASH-RT does not induce any 
macroscopic toxicity whereas 10GyCONV is the maximum 
tolerated dose (Acharya et al. 2009). We observed a 
memorization loss after 10GyCONV-RT whereas cognition is 
not affected at 50GyFLASH two months post-IR. At the same 
time point, SGZ BrdU+ clusters are maintained at doses up to 
20GyFLASH whereas 10GyCONV totally impairs the 
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neurogenesis. Concerning quiescence, more Sox2+NSCs 
express FoxO3 after 30GyFLASH-RT than in CONV-RT groups. 
Nevertheless, the number of Sox2+FoxO3+NSCs decreases at 
higher doses probably due to the RT-induced cell death. 
Altogether these results suggest that FLASH-WBRT induces 
different responses in the NSCs compared to CONV-RT. 
Indeed, FLASH-RT does not induce cognitive impairment two 
months post-IR compared to CONV-RT. This observation 
correlates with a preservation of neurogenesis in the SGZ. 
Moreover, after FLASH-RT, SVZ NSCs show a quiescent status 
which could explain their preservation after irradiation and 
their ability to re-induce neurogenesis. 
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Purpose: The purpose of the reported research is the 
elaboration of the method for construction of the cost-
effective whole-body single-bed positron emission 
tomography scanner enabling simultaneous PET/CT and 
PET/MRI imaging.   
Material and methods: The Jagiellonian Positron Emission 
Tomography scanner (J-PET) is built out of axially arranged 
plastic scintillator strips, forming a cylinder [1]. The light 
signals produced in scintillators are converted to electrical 
pulses by photomultipliers placed at opposite ends of each 
strip [2]. The pulses are probed in the voltage domain by a 
newly developed electronics [1,3], and are collected by the 
novel trigger-less and reconfigurable data acquisition system 
[1,4]. The hit-position and hit-time of gamma quanta are 
reconstructed based on the time of arrival of light signals to 
the ends of the scintillator strips. The reconstruction 
procedures make use of the compressing sensing theory [5,6] 
and the library of synchronized model signals [1,7]. 
Moreover, for the image reconstruction novel algorithms are 
being developed and adopted for fast iterations on the 
graphics processing units [8].  
For estimation of the J-PET characteristics the computer 
simulations were performed [9] using GATE package [10]. 
Simulations were conducted taking into account known 
physical and instrumental effects as e.g. photon emission 
spectrum, time distribution of emitted photons, losses and 
time spread of photons due to their propagation through the 
scintillator, as well as quantum efficiency and transit time 
spread of photomultipliers. 
Results: In autumn 2015 a construction of the full scale J-PET 
prototype was completed. J-PET consists of 192 strips 
arranged axially in three layers forming a cylindrical 
diagnostic chamber with the diameter of 85 cm and axial 
field-of-view (AFOV) of 50 cm, and it is characterized by 300 
ps coincidence resolving time.  
The performance characteristics, simulated according to 
standards defined by the National Electrical Manufacturers 
Association (NEMA-NU-2), indicate a comparable performance 
of the J-PET with respect to current TOF-PET modalities as 
regards e.g. accidental coincidences [9], sensitivity, scatter 
fraction and point spread function.  
Conclusions: An axial arrangement of long strips of plastic 
scintillators, and their small light attenuation allows us to 
make a TOF-PET scanner with a longAFOV. 
The estimated coincidence resolving time changes from 230 
ps to 430 ps when extending AFOV from 16 cm to 100 cm. 
This result opens perspectives for construction of the cost 
effective TOF-PET scanner with significantly improved TOF 
resolution and larger AFOV with respect to the current 
TOF-PET modalities [11,12]. 
The talk will include presentation of the J-PET scanner along 
with the description of its characteristics estimated 
according to NEMA-NU-2 standards, and presentation of 
perspectives of combining J-PET with CT and MRI. 
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Purpose: The radiolanthanide 161Tb (T1/2 = 6.89 d) emits β--
particles (Eβ- = 154 keV) similar to 177Lu (T1/2 = 6.64 d, Eβ- = 34 
KeV), but also a significant number of Auger electrons (~12e-
/decay). This radiation profile may result in more efficient 
tumor cell killing, in particular, if the radioconjugate targets 
the cellular nucleus where DNA is damaged by the short-
ranged Auger electrons. Herein, we investigated 161Tb in 
combination with folate and somatostatin analogs in vitro 
and in vivo and compared the results to those obtained with 
the 177Lu-labeled pendants. 
Materials/methods: 161Tb was produced via irradiation of a Gd 
target at the reactor at ILL and separated from the target 
material by ion exchange chromatography at PSI. A DOTA-
folate conjugate (cm10, [1]) was labeled with 161Tb and 177Lu 
and investigated in mice. The KB tumor sizes were measured 
and undesired side effects were monitored by determination 
of body weights and blood plasma parameters (BUN, 
creatinine), as well as histological investigation, as previously 
reported [2]. DOTATOC and its analog DOTATOC-NLS, which 
contains a nuclear localizing signal (NLS), were labeled with 
